ReMission Summit Opening Session

Opening Remarks

ReMission Alliance Update 

ReMission Scholarship Presentation 

Friends of Jacqueline Presentation   

Special Guest Speaker

Stefan Leichenauer, Sandbox Quantum

“AI, Quantum, and Current Medical Applications”

Session I

Pediatric Brain Tumor Immunotherapy 

Featuring:

Michael Taylor  – Toronto Sick Kids

“Group 4 Medulloblastoma is a hamartoma of the H. Sapiens rhombic lip, and could be prevented through post-natal screening and immunotherapy”

Elias Sayour – University of Florida

“Overcoming GBM immunosuppression with systemic mRNA delivery”

Tobey MacDonald – Emory

“Targeting STAT3, a Master Regulator of Anti-Tumor Immune Response, in Pediatric Medulloblastoma”

Session II 

Cancer Engineering 

Featuring:

Betty Kim – MD Anderson

“Engineering Approaches to Cancer Therapy”

Dennis Discher – U Penn 

“Engineered phagocytes for tumor elimination and anti-cancer vaccination”

Carlos Rinaldi – University of Florida

“Labeling immune cells with a new tracer tailored for sensitive tracking using magnetic particle imaging (MPI)”

Session III 

T Cells and Stem Cells

Featuring:

Jeremy Rich – University of Pittsburgh

Heike Daldrup-Link – Stanford

“Imaging CAR T-Cell Therapy”

Sue Kaech – Salk Institute

“Regulation of anti-tumor immune responses to GBM via microglia-CD4 T cell cross talk” 

Catherine Flores – University of Florida

“Stem cell immunotherapy against pediatric high grade gliomas”

Keynote Speaker

Leroy Hood, Institute for Systems Biology

“Beyond the Human Genome Program: A Million Person Demonstration on

the Science of Wellness and Prevention”

ReMission Summit Workshop & Discussion

“Disruptive Innovation in Brain Tumor Immunotherapy”

Session IV

Metabolism and  Microenvironment

Featuring:

Loic Deleyrolle – University of Florida

“Metabolic manipulation of T cells to treat brain tumors”

Anindya Bagchi – Sanford Burnham 

“Modulating mitochondrial dynamics to improve immune memory”

Dolares Hambardzumyan – Mount Sinai

“The Role of myeloid in Glioblastoma”

Justin Lathia – Cleveland Clinic

“Leveraging sex differences in the tumor microenvironment for more effective immunotherapies.”

Session V

Glioblastoma Immunity & Immunotherapy

Featuring:

Mark Gilbert – National Cancer Institute

“Optimizing Patient Selection for Immunotherapy: Biologic and Computational Approaches”

Peter Fecci – Duke

“The Undoing: The Demise of the T cell Amidst GBM”

Michael Platten – German Cancer Institute

“Immune targeting of shared clonal diver mutations in gliomas.”